Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Intervalo de año de publicación
1.
J Cosmet Dermatol ; 23(8): 2516-2523, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38853652

RESUMEN

BACKGROUND: While treatment is a definitive therapeutic component in the management of inflammatory skin conditions, adjunctive skin care comprising of appropriate cleansing, moisturization, and photoprotection are just as important. Cleansing, treatment, moisturization, and photoprotection (CTMP) constitute the four major components of holistic skincare routine for dermatological conditions. However, inadequate patient understanding of the condition, limited resources for physicians, and insufficient time for patient education during busy dermatological consultations are the main obstacles to establishing a holistic skincare routine in the real world. AIMS: This study aimed to identify key challenges in the implementation of a holistic skincare routine, and offer practical guidance to physicians to improve adoption in the management of acne, atopic dermatitis, rosacea, and sensitive skin syndrome. METHODS: An expert panel comprising of nine dermatologists from Australia, China, Hong Kong, Taiwan, India, Philippines, Singapore, South Korea, and Thailand convened to develop consensus statements to stimulate real-world adoption of holistic skincare routine in acne, rosacea, atopic dermatitis, and sensitive skin syndrome using the Delphi approach. RESULTS: Consensus was defined as ≥80% of panel rating statement as ≥8 or median rating of ≥8. The final statements were collated to develop consensus recommendations to encourage adoption of holistic skincare routine. CONCLUSION: Promoting patient education on the skin condition, training support staff in patient counseling, and offering physician training opportunities are the key strategies to encourage real-world adoption of CTMP as a holistic skincare routine. The consensus recommendations presented here should be considered in all dermatology patients to accomplish the ultimate goals of improved treatment outcomes and patient satisfaction.


Asunto(s)
Acné Vulgar , Consenso , Dermatitis Atópica , Salud Holística , Rosácea , Cuidados de la Piel , Humanos , Dermatitis Atópica/terapia , Rosácea/terapia , Acné Vulgar/terapia , Cuidados de la Piel/métodos , Educación del Paciente como Asunto , Técnica Delphi
2.
Dermatitis ; 33(6): 417-420, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36125779

RESUMEN

BACKGROUND: Nickel allergy is the most common contact allergy, and a nickel salt is, therefore, included in most baseline patch test series. In the baseline series of the International Contact Dermatitis Research Group and the American Contact Dermatitis Society, nickel sulfate hexahydrate (NSH) in petrolatum at 2.5% is included, whereas NSH at 5.0% is included in many other baseline series, such as the European and Swedish ones. OBJECTIVE: The aim of the study is to investigate whether NSH at 5.0% detects significantly more contact allergy than NSH 2.5% when both preparations are tested simultaneously in consecutive dermatitis patients. PATIENTS AND METHODS: Two thousand two hundred eighty-seven consecutive dermatitis patients were patch tested simultaneously with NSH in petrolatum at 2.5% and 5.0%. The allergy rates were compared for all clinics individually and combined using McNemar test, 2-sided. RESULTS: Contact allergy to NSH 5.0% and 2.5% was found in 20.3% and 16.8%, respectively ( P < 0.0001). In 6 of 11 clinics, significantly more patients tested positive to the higher NSH concentration. For the 2 clinics in North America combined, significantly more patients tested positive to NSH 5.0%. CONCLUSIONS: The NSH preparation in the International Contact Dermatitis Research Group baseline patch test series should be considered to be changed from NSH 2.5% (1 mg NSH/cm 2 ) to 5.0% (2 mg NSH/cm 2 ).


Asunto(s)
Dermatitis Alérgica por Contacto , Níquel , Humanos , Pruebas del Parche , Níquel/efectos adversos , Estudios Prospectivos , Dermatitis Alérgica por Contacto/diagnóstico , Dermatitis Alérgica por Contacto/epidemiología , Dermatitis Alérgica por Contacto/etiología , Vaselina , Alérgenos/efectos adversos
3.
Am J Trop Med Hyg ; 96(5): 1160-1163, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28138050

RESUMEN

AbstractSeveral case reports of autochthonous leishmaniasis in Thailand have been published since 1996. Most of the previous cases presented with visceral leishmaniasis (VL) and were mostly reported in southern part of Thailand. Recently, it has been evident that Leishmania martiniquensis is the main cause of Leishmania infection in Thailand. However, Leishmania siamensis (PCM2 Trang isolate) was found to be of a separate lineage with restricted distribution in southern Thailand and also a cause of disseminated dermal and visceral leishmaniasis in one published case. Here we report the first patient from central Thailand with human immunodeficiency virus infection presenting with disseminated dermal leishmaniasis. Polymerase chain reaction and DNA sequencing analysis (large subunit of RNA polymerase II and 18S ribosomal RNA internal transcribed spacer 1) from the tissue biopsy sample revealed the pathogen sequences to be highly homologous to PCM2 Trang strain previously reported from southern Thailand.


Asunto(s)
Antiprotozoarios/uso terapéutico , Antivirales/uso terapéutico , Dermis/patología , Infecciones por VIH/virología , Leishmaniasis Cutánea Difusa/parasitología , Adulto , Anfotericina B/uso terapéutico , Coinfección , ADN Espaciador Ribosómico/genética , Dermis/efectos de los fármacos , Dermis/parasitología , Dermis/virología , Femenino , VIH/efectos de los fármacos , VIH/crecimiento & desarrollo , Infecciones por VIH/diagnóstico , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/patología , Humanos , Itraconazol/uso terapéutico , Leishmania/efectos de los fármacos , Leishmania/genética , Leishmania/aislamiento & purificación , Leishmaniasis Cutánea Difusa/diagnóstico , Leishmaniasis Cutánea Difusa/tratamiento farmacológico , Leishmaniasis Cutánea Difusa/patología , Proteínas Protozoarias/genética , ARN Polimerasa II/genética , Análisis de Secuencia de ADN , Tailandia
4.
Dermatitis ; 27(5): 248-58, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27608064

RESUMEN

The International Contact Dermatitis Research Group proposes a classification for the clinical presentation of contact allergy. The classification is based primarily on the mode of clinical presentation. The categories are direct exposure/contact dermatitis, mimicking or exacerbation of preexisting eczema, multifactorial dermatitis including allergic contact dermatitis, by proxy, mimicking angioedema, airborne contact dermatitis, photo-induced contact dermatitis, systemic contact dermatitis, noneczematous contact dermatitis, contact urticaria, protein contact dermatitis, respiratory/mucosal symptoms, oral contact dermatitis, erythroderma/exfoliative dermatitis, minor forms of presentation, and extracutaneous manifestations.


Asunto(s)
Dermatitis Alérgica por Contacto/clasificación , Dermatitis Exfoliativa/clasificación , Dermatitis Fotoalérgica/clasificación , Progresión de la Enfermedad , Eccema/clasificación , Humanos , Mucositis/clasificación , Hipersensibilidad Respiratoria/clasificación , Urticaria/clasificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA